Human cellular prion protein interacts directly with clusterin protein

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1782, Issue 11, 2008, Pages 615-620

  Xu, Fei ^a   Karnaukhova, Elena ^a   Vostal, Jaroslav G ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Chaperone; Clusterin; Prion; Protein interaction; Two hybrid system

Indexed keywords

CLUSTERIN; PRION PROTEIN;

ALPHA CHAIN; ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; GENE DELETION; GENE MAPPING; GENE SEQUENCE; HYBRID; IMMUNOPRECIPITATION; ISOELECTRIC FOCUSING; MOLECULAR CLONING; MOLECULAR MECHANICS; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; WESTERN BLOTTING;

ANIMALS; CELL LINE; CLUSTERIN; HUMANS; LIGANDS; MOLECULAR CHAPERONES; PROTEIN BINDING; PROTEIN SUBUNITS; PRPC PROTEINS; TWO-HYBRID SYSTEM TECHNIQUES;

MAMMALIA;

EID: 55049133701     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2008.08.004     Document Type: Article

References (42)

1. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13363-13383
2. Wadsworth J.D., and Collinge J. Update on human prion disease. Biochim. Biophys. Acta 1772 (2007) 598-609
3. Johnson R.T. Prion diseases. Lancet. Neurol. 4 (2005) 635-642
4. van Rheede T., Smolenaars M.M., Madsen O., and de Jong W.W. Molecular evolution of the mammalian prion protein. Mol. Biol. Evol. 20 (2003) 111-121
5. Bueler H., Fischer M., Lang Y., Bluethmann H., Lipp H.P., DeArmond S.J., Prusiner S.B., Aguet M., and Weissmann C. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356 (1992) 577-582
6. Manson J.C., Clarke A.R., Hooper M.L., Aitchison L., McConnell I., and Hope J. 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol. Neurobiol. 8 (1994) 121-127
7. Richt J.A., Kasinathan P., Hamir A.N., Castilla J., Sathiyaseelan T., Vargas F., Sathiyaseelan J., Wu H., Matsushita H., Koster J., Kato S., Ishida I., Soto C., Robl J.M., and Kuroiwa Y. Production of cattle lacking prion protein. Nat. Biotechnol. 25 (2007) 132-138
8. Edenhofer F., Rieger R., Famulok M., Wendler W., Weiss S., and Winnacker E.L. Prion protein PrPc interacts with molecular chaperones of the Hsp60 family. J. Virol. 70 (1996) 4724-4728
9. Sun G., Guo M., Shen A., Mei F., Peng X., Gong R., Guo D., Wu J., Tien P., and Xiao G. Bovine PrPC directly interacts with alphaB-crystalline. FEBS Lett. 579 (2005) 5419-5424
10. Beck K.E., Kay J.G., and Braun J.E. Rdj2, a J protein family member, interacts with cellular prion PrP(C). Biochem. Biophys. Res. Commun. 346 (2006) 866-871
11. Azzalin A., Ferrara V., Arias A., Cerri S., Avella D., Pisu M.B., Nano R., Bernocchi G., Ferretti L., and Comincini S. Interaction between the cellular prion (PrPC) and the 2P domain K+ channel TREK-1 protein. Biochem. Biophys. Res. Commun. 346 (2006) 108-115
12. Bragason B.T., and Palsdottir A. Interaction of PrP with NRAGE, a protein involved in neuronal apoptosis. Mol. Cell Neurosci. 29 (2005) 232-244
13. Spielhaupter C., and Schatzl H.M. PrPC directly interacts with proteins involved in signaling pathways. J. Biol. Chem. 276 (2001) 44604-44612
14. Rieger R., Edenhofer F., Lasmezas C.I., and Weiss S. The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nat. Med. 3 (1997) 1383-1388
15. Kurschner C., and Morgan J.I. The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid system. Brain Res. Mol. Brain Res. 30 (1995) 165-168
16. Westergard L., Christensen H.M., and Harris D.A. The cellular prion protein (PrP(C)): Its physiological function and role in disease. Biochim. Biophys. Acta 1772 (2007) 629-644
17. Ecroyd H., Belghazi M., Dacheux J.L., and Gatti J.L. The epididymal soluble prion protein forms a high-molecular-mass complex in association with hydrophobic proteins. Biochem. J. 392 (2005) 211-219
18. Schmitt-Ulms G., Hansen K., Liu J., Cowdrey C., Yang J., DeArmond S.J., Cohen F.E., Prusiner S.B., and Baldwin M.A. Time-controlled transcardiac perfusion cross-linking for the study of protein interactions in complex tissues. Nat. Biotechnol. 22 (2004) 724-731
19. Kempster S., Collins M.E., Aronow B.J., Simmons M., Green R.B., and Edington N. Clusterin shortens the incubation and alters the histopathology of bovine spongiform encephalopathy in mice. Neuroreport 15 (2004) 1735-1738
20. Rost B., Yachdav G., and Liu J. The PredictProtein server. Nucleic Acids Res. 32 (2004) W321-326
21. Leskov K.S., Klokov D.Y., Li J., Kinsella T.J., and Boothman D.A. Synthesis and functional analyses of nuclear clusterin, a cell death protein. J. Biol. Chem. 278 (2003) 11590-11600
22. Stewart R.S., and Harris D.A. Most pathogenic mutations do not alter the membrane topology of the prion protein. J. Biol. Chem. 276 (2001) 2212-2220
23. Hegde R.S., Mastrianni J.A., Scott M.R., DeFea K.A., Tremblay P., Torchia M., DeArmond S.J., Prusiner S.B., and Lingappa V.R. A transmembrane form of the prion protein in neurodegenerative disease. Science 279 (1998) 827-834
24. McHattie S., and Edington N. Clusterin prevents aggregation of neuropeptide 106-126 in vitro. Biochem. Biophys. Res. Commun. 259 (1999) 336-340
25. Manuelidis L., Fritch W., and Xi Y.G. Evolution of a strain of CJD that induces BSE-like plaques. Science 277 (1997) 94-98
26. Sasaki K., Doh-ura K., Ironside J.W., and Iwaki T. Increased clusterin (apolipoprotein J) expression in human and mouse brains infected with transmissible spongiform encephalopathies. Acta Neuropathol. (Berl.) 103 (2002) 199-208
27. Sasaki K., Doh-ura K., Ironside J., Mabbott N., and Iwaki T. Clusterin expression in follicular dendritic cells associated with prion protein accumulation. J. Pathol. 209 (2006) 484-491
28. McHattie S., Wells G.A., Bee J., and Edington N. Clusterin in bovine spongiform encephalopathy (BSE). J. Comp. Pathol. 121 (1999) 159-171
29. Freixes M., Puig B., Rodriguez A., Torrejon-Escribano B., Blanco R., and Ferrer I. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease. Acta Neuropathol. (Berl.) 108 (2004) 295-301
30. DeMattos R.B., Cirrito J.R., Parsadanian M., May P.C., O'Dell M.A., Taylor J.W., Harmony J.A., Aronow B.J., Bales K.R., Paul S.M., and Holtzman D.M. ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron 41 (2004) 193-202
31. Yerbury J.J., Poon S., Meehan S., Thompson B., Kumita J.R., Dobson C.M., and Wilson M.R. The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J. (2007)
32. DeMattos R.B., O'Dell M A., Parsadanian M., Taylor J.W., Harmony J.A., Bales K.R., Paul S.M., Aronow B.J., and Holtzman D.M. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 10843-10848
33. Calero M., Rostagno A., Frangione B., and Ghiso J. Clusterin and Alzheimer's disease. Subcell Biochem. 38 (2005) 273-298
34. Wilson M.R., and Easterbrook-Smith S.B. Clusterin is a secreted mammalian chaperone. Trends Biochem. Sci. 25 (2000) 95-98
35. Humphreys D.T., Carver J.A., Easterbrook-Smith S.B., and Wilson M.R. Clusterin has chaperone-like activity similar to that of small heat shock proteins. J. Biol. Chem. 274 (1999) 6875-6881
36. Zlokovic B.V., Martel C.L., Matsubara E., McComb J.G., Zheng G., McCluskey R.T., Frangione B., and Ghiso J. Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 4229-4234
37. Chiti F., and Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75 (2006) 333-366
38. Wisniewski T., and Sigurdsson E.M. Therapeutic approaches for prion and Alzheimer's diseases. FEBS J. (2007)
39. Crozet C., Lin Y.L., Mettling C., Mourton-Gilles C., Corbeau P., Lehmann S., and Perrier V. Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations. J. Cell Sci. 117 (2004) 5591-5597
40. Schmitz G. Drug evaluation: OGX-011, a clusterin-inhibiting antisense oligonucleotide. Curr. Opin. Mol. Ther. 8 (2006) 547-554
41. Biroccio A., D'Angelo C., Jansen B., Gleave M.E., and Zupi G. Antisense clusterin oligodeoxynucleotides increase the response of HER-2 gene amplified breast cancer cells to Trastuzumab. J. Cell Physiol. 204 (2005) 463-469
42. Shannan B., Seifert M., Leskov K., Willis J., Boothman D., Tilgen W., and Reichrath J. Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death Differ. 13 (2006) 12-19